Literature DB >> 3356890

Jejunal adenocarcinoma in congenital heterotopic gastric mucosa.

M L Caruso1, F Marzullo.   

Abstract

We describe an adenocarcinoma of the jejunum that developed in congenital heterotopic gastric mucosa, a rare event. In our patient, the absence of other intestinal malformation and the presence of gastric glands with variable grades of dysplasia, together with the histological pattern of the tumor, strongly favor the possible origin of the neoplasia from the heterotopic gastric glands, rather than from intestinal ones.

Entities:  

Mesh:

Year:  1988        PMID: 3356890     DOI: 10.1097/00004836-198802000-00020

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

1.  High chromosomal instability in adenocarcinoma of the ileum arising from multifocal gastric heterotopia with gastritis cystica profunda.

Authors:  Inga-Marie Schaefer; Philipp Schüler; Christina Enders; Jens-Gerd Scharf; Silke Cameron; Giuliano Ramadori; László Füzesi
Journal:  Med Oncol       Date:  2010-06-25       Impact factor: 3.064

2.  Colonic adenocarcinoma arising from gastric heterotopia: a case study.

Authors:  Hyoungsuk Ko; Shin Young Park; Eun Jung Cha; Jang Sihn Sohn
Journal:  Korean J Pathol       Date:  2013-06-25

3.  Mass-Forming Gastric Heterotopia of the Rectum: A Series of 3 Cases from a Single Tertiary Health Center.

Authors:  Jeffrey D Covington; Yang Zong; Arslan Talat; Cara Strock; Keith Tomaszewicz; Jaroslav Zivny; Michelle X Yang
Journal:  Am J Case Rep       Date:  2022-07-26

4.  Intestinal submucous fibrovascular hamartoma: A case report.

Authors:  Jin Liu; Yanjun Liu; Ziyao Ji
Journal:  Radiol Case Rep       Date:  2021-05-23

5.  Small bowel capsule endoscopy revealing neuromuscular and vascular hamartoma of the jejunum: A case report.

Authors:  Maria L Caruso; Elisabetta Cavalcanti; Francesco De Michele; Antonia Ignazzi; Roberta Carullo; Mauro Mastronardi
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.